Constellium's future performance is deemed crucial for shareholders despite expected slowdown in share price growth. However, investors should be aware of the 3 identified warning signs with the company.
Constellium's decent ROE is overshadowed by its high debt level. A high-quality business is one that can achieve high ROE without debt. Between two companies with the same ROE, the less indebted one is generally preferred.
Constellium股票讨论
对收益/指导的回应:
• $梯瓦制药(TEVA.US)$ +24%(还宣布了阿片类药物结算协议), $Enphase Energy(ENPH.US)$ +9.5%, $Spotify Technology(SPOT.US)$ +9.2%, $RPC Inc(RES.US)$ +8.5%, $奇波雷墨西哥烧烤(CMG.US)$ +8.2%, $Manhattan Associates(MANH.US)$ +8.1%, $希尔顿酒店(HLT.US)$ +6.7%, $ChampionX(CHX.US)$ +6.1%, $Mr. Cooper Group(COOP.US)$ +5.7%, $Constellium(CSTM.US)$ +5.5%, $波士顿科学(BSX.US)$ +5.4%,...
暂无评论